CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 72 filers reported holding CULLINAN ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $212,983 | +140.6% | 23,534 | +186.1% | 0.00% | – |
| Q2 2023 | $88,512 | -49.8% | 8,226 | -52.3% | 0.00% | – |
| Q1 2023 | $176,355 | +1384.6% | 17,239 | +1431.0% | 0.00% | – |
| Q4 2022 | $11,879 | -30.1% | 1,126 | -15.5% | 0.00% | – |
| Q3 2022 | $17,000 | -57.5% | 1,333 | -57.3% | 0.00% | – |
| Q2 2022 | $40,000 | -64.6% | 3,123 | -71.0% | 0.00% | – |
| Q1 2022 | $113,000 | -87.9% | 10,757 | -82.3% | 0.00% | -100.0% |
| Q4 2021 | $936,000 | +1200.0% | 60,678 | +1813.5% | 0.00% | – |
| Q3 2021 | $72,000 | +227.3% | 3,171 | +265.7% | 0.00% | – |
| Q2 2021 | $22,000 | -78.6% | 867 | -64.9% | 0.00% | – |
| Q1 2021 | $103,000 | – | 2,470 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 7,648,268 | $118,013,000 | 21.52% |
| CHI Advisors LLC | 2,476,720 | $38,215,000 | 12.68% |
| Nextech Invest Ltd. | 1,221,145 | $18,842,000 | 4.96% |
| Foresite Capital Management V, LLC | 1,143,006 | $17,637,000 | 4.33% |
| Foresite Capital Opportunity Management V, LLC | 381,002 | $5,879,000 | 3.94% |
| BVF INC/IL | 5,369,459 | $82,851,000 | 3.01% |
| Boxer Capital, LLC | 1,074,082 | $16,573,000 | 0.64% |
| Logos Global Management LP | 288,458 | $4,450,000 | 0.46% |
| Birchview Capital, LP | 45,114 | $696,000 | 0.45% |
| Eventide Asset Management | 1,440,145 | $21,665,000 | 0.28% |